SILK-Aß

Serial Number 77510907
Registration 3835671
800

Registration Progress

Application Filed
Jun 30, 2008
Under Examination
Feb 17, 2009
Approved for Publication
Nov 5, 2008
Published for Opposition
Nov 25, 2008
Registered
Aug 17, 2010

Trademark Image

SILK-Aß

Basic Information

Serial Number
77510907
Registration Number
3835671
Filing Date
June 30, 2008
Registration Date
August 17, 2010
Published for Opposition
November 25, 2008
Renewal Date
August 17, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 24, 2021
Registration
Registered
Classes
005

Rights Holder

C2N Diagnostics, LLC

16
Address
4240 Duncan Avenue
St. Louis, MO 63110

Ownership History

C2N Diagnostics, LLC

Original Applicant
16
Pikesville, MD

C2N Diagnostics, LLC

Owner at Publication
16
Pikesville, MD

C2N Diagnostics, LLC

Original Registrant
16
St. Louis, MO

Legal Representation

Attorney
Matthew P. Frederick

USPTO Deadlines

Next Deadline
1861 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2010-08-17)
Due Date
August 17, 2030
Grace Period Ends
February 17, 2031

Application History

50 events
Date Code Type Description
Sep 22, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 22, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 22, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 22, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 22, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 25, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 24, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 24, 2021 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 24, 2021 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 24, 2021 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Jan 13, 2021 E89R I TEAS SECTION 8 & 9 RECEIVED
Aug 17, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 24, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 24, 2016 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 24, 2016 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 18, 2016 E815 I TEAS SECTION 8 & 15 RECEIVED
Aug 17, 2010 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 15, 2010 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 14, 2010 ALIE A ASSIGNED TO LIE
Jul 14, 2010 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
Jun 28, 2010 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 8, 2010 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jun 3, 2010 EISU I TEAS STATEMENT OF USE RECEIVED
Jun 3, 2010 IUAF S USE AMENDMENT FILED
Mar 20, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 19, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 19, 2010 EX2G S SOU EXTENSION 2 GRANTED
Feb 16, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 16, 2010 EXT2 S SOU EXTENSION 2 FILED
Aug 12, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 12, 2009 EXT1 S SOU EXTENSION 1 FILED
Aug 12, 2009 EX1G S SOU EXTENSION 1 GRANTED
Feb 17, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Nov 25, 2008 PUBO A PUBLISHED FOR OPPOSITION
Nov 5, 2008 NPUB O NOTICE OF PUBLICATION
Oct 23, 2008 ALIE A ASSIGNED TO LIE
Oct 23, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 10, 2008 CNRT R NON-FINAL ACTION WRITTEN
Oct 10, 2008 GNRT F NON-FINAL ACTION E-MAILED
Oct 10, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 10, 2008 CNEA R EXAMINERS AMENDMENT -WRITTEN
Oct 10, 2008 GNEA O EXAMINERS AMENDMENT E-MAILED
Oct 10, 2008 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 10, 2008 XAEC I EXAMINER'S AMENDMENT ENTERED
Oct 10, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2008 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
medical diagnostic reagents and assays for use in testing pharmaceutical preparations influencing the central nervous system
First Use Anywhere: May 4, 2010
First Use in Commerce: May 4, 2010

Classification

International Classes
005

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO